Genflow Biosciences issues 28,124,999 shares on warrant exercise

The company received notices to exercise warrants for 28,124,999 new ordinary shares, with gross proceeds of £309,375. Admission is expected on or around 2 October 2026, after which total voting rights will be 594,534,781.